about
Chemotherapy for second-stage Human African trypanosomiasisChemotherapy for second-stage Human African trypanosomiasisOptions for field diagnosis of human african trypanosomiasisNifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case seriesEstimates of the duration of the early and late stage of gambiense sleeping sicknessThe human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forwardEvolution of a strategy for preparing bioactive small molecules by sequential multicomponent assembly processes, cyclizations, and diversificationCivil conflict and sleeping sickness in Africa in general and Uganda in particular.First small molecular inhibitors of T. brucei dolicholphosphate mannose synthase (DPMS), a validated drug target in African sleeping sickness.New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289Acetate and succinate production in amoebae, helminths, diplomonads, trichomonads and trypanosomatids: common and diverse metabolic strategies used by parasitic lower eukaryotes.The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in african trypanosomes.Retaking sleeping sickness control in Angola.Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project.[African sleeping sickness. An ancient threat returns].A new transmission risk index for human African trypanosomiasis and its application in the identification of sites of high transmission of sleeping sickness in the Fontem focus of southwest Cameroon.
P2860
Q24201785-BDCE64E2-7CCD-4530-857F-AEC71226FF4FQ24236290-F265A0F8-48A9-4933-9FAB-F96F323FF0E2Q24557540-8CD30352-6D86-4DB9-91AC-3C329E07DAC9Q28471706-421491C0-1923-4B7B-80C6-C417E4C465F1Q28755434-C40AF53A-22B9-4D4A-BDC4-95558B2DC535Q33834072-417395CA-F87E-4731-A598-90FE4E74D9D7Q34207033-95ED2AFF-C93E-42D8-8C47-1D17F3C92274Q35750445-40F2700D-9B7B-4C2D-8958-515839CB57F3Q37098728-7204D7FD-4640-4764-A731-7C6D0550F795Q37392888-46FDC716-3EBE-4E44-B133-2D22855CF7A2Q37661156-3A11DC24-9689-4551-AA8C-1BDF2D7C3DB0Q37734328-C82709F9-479A-4F73-93FA-676814C7ADE7Q38856795-BF5D3B08-AE8E-476E-BB8E-B85DA6BF10CAQ39078466-DFE7FFBC-4821-49BC-922E-89EA50741118Q52699729-6A9DD2D7-F762-4E63-97F5-F247ADBDD26BQ52713481-0A5308A4-43CA-4106-A4B2-F819FC5CC14C
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Waking up to sleeping sickness.
@ast
Waking up to sleeping sickness.
@en
type
label
Waking up to sleeping sickness.
@ast
Waking up to sleeping sickness.
@en
prefLabel
Waking up to sleeping sickness.
@ast
Waking up to sleeping sickness.
@en
P1476
Waking up to sleeping sickness.
@en
P2093
August Stich
Michael P Barrett
P304
P356
10.1016/S1471-4922(03)00055-2
P577
2003-05-01T00:00:00Z